Le Lézard
Classified in: Health
Subjects: AVO, CFG, MAT

STOP USING PEOPLE WHO VAPE AS A BOTTOMLESS PIGGYBANK


TORONTO, Nov. 6, 2023 /CNW/ - Rights4Vapers, Canada's largest vapers' rights movement, calls on the Government of Ontario to refrain from jumping on the taxation bandwagon and penalizing Ontarians who vape even more.

"We are at a critical moment for vapour products. We are being attacked from every angle," said Maria Papaioannoy, spokesperson for Rights4Vapers. "All we want is for adult Canadians who smoke to have an affordable less-harmful choice. Signing on to the federal government's proposal to add a matching provincial excise tax to vapour products will increase a 60 ml bottle of e-liquid by $10 to $44.95. We must keep vapour products affordable."

The province said that taxation is a "proven and well-established approach to deterring the consumption of products that pose health risk." We would like to ask the finance minister what health risks is he talking about exactly. Vaping is 95 percent less harmful than smoking.

"The smoking rate in Ontario is 9.9 percent ? an all-time low ? just below the national average of 10.3 percent. Clearly the government is losing money. Fewer people smoke. Less tobacco tax collected," said Ms. Papaioannoy. "So, what do they do? Target the only real harm-reduced product on the market and drive up the taxation on it. Maybe they want to get people smoking again? It's mindboggling that the Ontario government is not seeing the bigger picture."

Our opposition to dramatic increases in taxation is based on the premise that vapour products are an effective tobacco harm reduction tool and a proven method to help adult smokers quit smoking, as such they should remain as affordable as possible. Any increase in price closes the gap between vapour products and cigarettes. A cheaper vapour product is much more appealing to an adult smoker than a cigarette ? especially to someone who is looking for an alternative to smoking.

Any additional tax on vapour products will simply move sales into the black market. We know that the criminals who sell illegal vapour and tobacco products do not comply with any safety regulations, nor do they collect taxes, and, perhaps most concerning of all, they have no problem with selling any product to minors.

"Ontarians who vape deserve so much better than to be treated as a piggybank to fill government coffers. All we want is an affordable alternative to smoking. The finance minister will be hearing this message loud and clear in the weeks ahead," said Ms. Papaioannoy.

Rights4Vapers is an organization of vaping advocates dedicated to the advancement of Canadian based research on vaping. Rights4Vapers is the voice of Canadian adult vapers, 98 percent of whom are former smokers.

SOURCE Rights 4 Vapers


These press releases may also interest you

at 04:45
ERS Genomics Limited (?ERS'), the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS' CRISPR/Cas9 patent portfolio....

at 03:15
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 02:30
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....



News published on and distributed by: